2021, Number 1
Clinical overview of COVID-19 behavior in Puebla: Prevalence and Severity
Language: Spanish
References: 32
Page: 39-56
PDF size: 557.60 Kb.
ABSTRACT
On February 27, the first case of COVID-19 was confirmed in Mexico, a disease caused by the SARS Cov-2 virus. Until August 7, data from the John Hopkins University show 201 million infected, while in Mexico 2.94 million infected in the world, causing 4.27 million deaths. Objective: To describe the clinical behavior and characteristics associated with severity/ mortality in COVID-19. Methods: Data from 280 patients confirmed to COVID-19 by RT PCR were obtained, with moderate and severe clinical expressions that warranted hospital management at the High Specialty Medical Unit in Puebla from March 1 to June 30, 2020. Results: The mean age was 54.31 years and 63.57% (n = 178) were men. The comorbidities found were overweight: 49.28% (n = 138), obesity: 35% (n = 98), systemic arterial hypertension: 25.35% (n = 71), diabetes mellitus: 24.64% (n = 69), kidney transplantation: 5% (n = 12). Respiratory symptoms were reported in 86.07% (n = 241). Of the total number of patients, only 15.71% (44) required ventilatory mechanical assistance. The risk factors associated with death were Systemic Arterial Hypertension (SAH) OR = 5.31 (95% CI 2.14- 12.75), Male sex OR = 4.77 (95% CI 1.65-13.84), Mechanical-Ventilatory Assistance (AMV) OR = 3.2 (95% CI 1.3-7.86), transplantation OR= 102 (95% CI 14.91-699) and there was a protective factor called respiratory symptoms OR = 0.12 (95% CI 0.05-0.3). Conclusion: COVID 19 is more prevalent in men. The mortality rate was 17.5% (49/280). The risk factors for mortality were SAH, male sex, AMV, Transplantation and finally, respiratory symptom was a protective factor.REFERENCES
Bello-Chavolla, O. Y., Bahena-López, J. P., Antonio-Villa, N. E., Vargas-Vázquez, A., González-Díaz, A., Márquez-Salinas, A., Aguilar-Salinas, C. A. (2020). Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. The Journal of Clinical Endocrinology and Metabolism, 105(8), 2752–2761. https://doi.org/10.1210/clinem/dgaa346
Casas-Rojo, J. M., Antón-Santos, J. M., Millán-Núñez-Cortés, J., Lumbreras- Bermejo, C., Ramos-Rincón, J. M., Roy-Vallejo, E., … Gómez- Huelgas, R. (2020). Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry. Revista Clinica Espanola, 220(8), 480–494. https://doi.org/ 10.1016/j.rce.2020.07.003
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Cas- telli, A., Pesenti, A. (2020). Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA - Journal of the American Medical Association, 323(16), 1574–1581. https://doi.org/10.1001/jama.2020.5394
Gupta, A. K., Jneid, H., Addison, D., Ardehali, H., Boehme, A. K., Borgaonkar, S., … London, B. (2020). Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors. Journal of the American Heart Association, 9(12), 1–23. https://doi.org/10.1161/JAHA.120.017013
Maitra, S., Som, A., & Bhattacharjee, S. (2018). Accuracy of quick Sequential Organ Failure Assessment (qSOFA) score and systemic inflammatory response syndrome (SIRS) criteria for predicting mortality in hospitalized patients with suspected infection: a meta-analysis of observational studies. Clinical Microbiology and Infection, 24(11), 1123–1129. https://doi.org/10.1016/j.cmi.2018.03.032
Organización Panamericana de la Salud. (2020). Definiciones de casos para la vigilancia COVID-19 - 7 de agosto de 2020. Retrieved August 19, 2020, from Organizaciòn Mundial de la Salud website: https:// www.paho.org/es/temas/coronavirus/brote-enfermedad-por-coronavirus- covid-19/definiciones-casos-para-vigilancia
Petrova, D., Salamanca-Fernández, E., Rodríguez Barranco, M., Navarro Pérez, P., Jiménez Moleón, J. J., & Sánchez, M.-J. (2020). La obesidad como factor de riesgo en personas con COVID-19: posibles mecanismos e implicaciones. Atención Primaria, 52(7), 496–500. https://doi. org/10.1016/j.aprim.2020.05.003
Shamah, T., Gómez, M., Mundo, V., Cuevas, L., Gaona, E., MA, A., Rivera, J. (2020). ENSARS-COV-2: Resultados de la evaluación basal de la encuesta nacional de las características de la población durante la pandemia de covid-19. In Instituto Nacional de Salud Pública. Retrieved from https://www.insp.mx/avisos/5463-resultados-encuesta- ensars-coronavirus-ensanut.html
Viveiros, A., Rasmuson, J., Vu, J., Mulvagh, S. L., Yip, C. Y. Y., Norris, C. M., & Oudit, G. Y. (2021). Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. American Journal of Physiology-Heart and Circulatory Physiology, 320(1), 296H304. https://doi.org/10.1152/ ajpheart.00755.2020
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - Journal of the American Medical Association, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
Williams, Bryan; Giuseppe, Mancia; Spiering, Wilko; Agabiti Rosei, Enrico; Azizi, Michel; Burnier, Michel; Clement, Denis L; Coca, A. et al. (2019). Guía ESC/ ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial. Revista Española de Cardiología, 72(2), 160–178. https://doi.org/10.1016/j. recesp.2018.12.005